Indication-specific pricing for cancer drugs Journal Article
| Author: | Bach, P. B. |
| Article Title: | Indication-specific pricing for cancer drugs |
| Keywords: | cancer survival; overall survival; erlotinib; drug efficacy; drug safety; antineoplastic agents; united states; paclitaxel; pancreas cancer; outcome assessment; antineoplastic agent; treatment indication; quality control; metastasis; quality of life; breast cancer; practice guideline; food and drug administration; cetuximab; cancer therapy; europe; health care policy; cost control; cost effectiveness analysis; drug cost; medicare; prescription; economics; drug costs; health policy; drug research; drug distribution; insurance; malignant neoplastic disease; health care system; short survey; trastuzumab; breast metastasis; head and neck carcinoma; drug indication; non small cell lung cancer; head and neck squamous cell carcinoma; human; article |
| Journal Title: | JAMA - Journal of the American Medical Association |
| Volume: | 312 |
| Issue: | 16 |
| ISSN: | 0098-7484 |
| Publisher: | American Medical Association |
| Date Published: | 2014-10-22 |
| Start Page: | 1629 |
| End Page: | 1630 |
| Language: | English |
| DOI: | 10.1001/jama.2014.13235 |
| PUBMED: | 25279433 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Export Date: 1 December 2014 -- Source: Scopus |
